1. Home
  2. RANG vs PROF Comparison

RANG vs PROF Comparison

Compare RANG & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANG
  • PROF
  • Stock Information
  • Founded
  • RANG 2024
  • PROF N/A
  • Country
  • RANG United States
  • PROF Canada
  • Employees
  • RANG N/A
  • PROF N/A
  • Industry
  • RANG
  • PROF Medical/Dental Instruments
  • Sector
  • RANG
  • PROF Health Care
  • Exchange
  • RANG Nasdaq
  • PROF Nasdaq
  • Market Cap
  • RANG 165.2M
  • PROF 149.7M
  • IPO Year
  • RANG 2024
  • PROF N/A
  • Fundamental
  • Price
  • RANG $10.14
  • PROF $5.27
  • Analyst Decision
  • RANG
  • PROF Strong Buy
  • Analyst Count
  • RANG 0
  • PROF 2
  • Target Price
  • RANG N/A
  • PROF $11.50
  • AVG Volume (30 Days)
  • RANG 5.8K
  • PROF 84.1K
  • Earning Date
  • RANG 01-01-0001
  • PROF 05-08-2025
  • Dividend Yield
  • RANG N/A
  • PROF N/A
  • EPS Growth
  • RANG N/A
  • PROF N/A
  • EPS
  • RANG N/A
  • PROF N/A
  • Revenue
  • RANG N/A
  • PROF $11,862,000.00
  • Revenue This Year
  • RANG N/A
  • PROF $71.17
  • Revenue Next Year
  • RANG N/A
  • PROF $134.25
  • P/E Ratio
  • RANG N/A
  • PROF N/A
  • Revenue Growth
  • RANG N/A
  • PROF 75.01
  • 52 Week Low
  • RANG $9.91
  • PROF $3.90
  • 52 Week High
  • RANG $10.64
  • PROF $11.42
  • Technical
  • Relative Strength Index (RSI)
  • RANG N/A
  • PROF 56.43
  • Support Level
  • RANG N/A
  • PROF $5.11
  • Resistance Level
  • RANG N/A
  • PROF $5.38
  • Average True Range (ATR)
  • RANG 0.00
  • PROF 0.34
  • MACD
  • RANG 0.00
  • PROF 0.10
  • Stochastic Oscillator
  • RANG 0.00
  • PROF 87.93

About RANG Range Capital Acquisition Corp. Ordinary Shares

Range Capital Acquisition Corp is a blank check company.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: